Siglec-7 represents a glyco-immune checkpoint for non-exhausted effector memory CD8+ T cells with high functional and metabolic capacities

Overview of attention for article published in Frontiers in immunology, September 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 6,369 followers.

RT @AsAshraf123321: #glycotime @AndrejBenjak +others identified Siglec-7 as a glyco-immune checkpoint expressed on non-exhausted effector m…

12 Oct 2022

Reply Repost Favourite

RT @AsAshraf123321: #glycotime @AndrejBenjak +others identified Siglec-7 as a glyco-immune checkpoint expressed on non-exhausted effector m…

12 Oct 2022

Reply Repost Favourite

RT @AsAshraf123321: #glycotime @AndrejBenjak +others identified Siglec-7 as a glyco-immune checkpoint expressed on non-exhausted effector m…

12 Oct 2022

Reply Repost Favourite

#glycotime @AndrejBenjak +others identified Siglec-7 as a glyco-immune checkpoint expressed on non-exhausted effector memory CD8+ T cells.Their findings project Siglec-7 as a glyco-immune checkpoint & therapeutic target for T cell-driven disorders &amp

12 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.